Alzheimer's study seeks to match drug to patients using brain clues
NCT ID NCT03703856
First seen Nov 06, 2025 · Last updated May 12, 2026 · Updated 27 times
Summary
This study looked at whether certain brain measurements can predict how well people with Alzheimer's disease respond to the drug memantine. Fifty-three participants took memantine for 24 weeks, and researchers tracked changes in thinking and behavior. The goal was to find biomarkers that could help doctors personalize treatment in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Teaching Facility (CTF-B102) at UCSD Medical Center
San Diego, California, 92103, United States
Conditions
Explore the condition pages connected to this study.